TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical stories of the week.
This week's topics include dulaglutide (Trulicity) or tirzepatide (Mounjaro), hepatitis C treatment, drugs for fatigue in long COVID, and biopharma c...
The strongest version of this narrative highlights critical shifts in global health innovation and treatment efficacy. The migration of biopharmaceutical development away from the U.S. underscores a strategic vulnerability, particularly in supply chain resilience and intellectual property control. The fluvoxamine study offers a rare glimmer of hope for long COVID patients, though its geographic limitation to Brazil warrants broader validation. The decline in hepatitis C treatment uptake, despite...